BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million and is providing Q2 2024 Revenue Guidance of $5.7-$6.0 millionManagement pursuing Nasdaq listing by end of year.
SiriusXM Reports First Quarter 2024 Operating and Financial Results
SiriusXM (NASDAQ: SIRI) today reported operating and financial results for the first quarter of 2024, which have been posted to the Investor Relations section of the SiriusXM website at The company will also host a live webcast for investors today at 8:00 a.
The biopharmaceutical giant topped its earnings and revenue estimates thanks to strong sales of its HIV, liver disease, and ...
13h
The campus will include up to six high-rises with apartments and laboratory space for life sciences and other research ...
The 2023 Valuation Report values Xlife Sciences' portfolio as of December 31, 2023, in a range between CHF 611.7 million (previous year: CHF 576 million) and CHF 747.8 million (previous year: CHF ...
The verdict was announced on April 26, following a 5-day trial by jury. According to a press release from Sight Sciences, the ...
Paris has felt surprisingly apolitical these last few months. But something changed: Students occupied one of France’s most ...
The Trade: Abrdn Life Sciences Investors HQL 10% owner Boaz Weinstein bought a total of 120,304 shares at an average price of ...
The study analyzed more than 100 U.S. metros looking at several key indicators, such as innovation, talent pool, and life ...
Suspension will be in force until calm and security restored at the school Protesters dance as they stage a sit-in near the ...
Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT:93X) (the "Company" or "Promino") is pleased to ...
On Wednesday, the American Academy of Arts and Sciences announced 250 new members for 2024, including three Brown University ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teladoc (TDOC – Research Report), R1 RCM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback